158 related articles for article (PubMed ID: 3876153)
1. Intimal hyperplasia in autogenous vein grafts used for arterial bypass: a canine model.
Landymore RW; Kinley CE; Cameron CA
Cardiovasc Res; 1985 Sep; 19(9):589-92. PubMed ID: 3876153
[TBL] [Abstract][Full Text] [Related]
2. Cod-liver oil in the prevention of intimal hyperplasia in autogenous vein grafts used for arterial bypass.
Landymore RW; Kinley CE; Cooper JH; MacAulay M; Sheridan B; Cameron C
J Thorac Cardiovasc Surg; 1985 Mar; 89(3):351-7. PubMed ID: 3974270
[TBL] [Abstract][Full Text] [Related]
3. Correlation between the effects of aspirin and dipyridamole on platelet function and prevention of intimal hyperplasia in autologous vein grafts.
Landymore RW; Karmazyn M; MacAulay MA; Sheridan B; Cameron CA
Can J Cardiol; 1988; 4(1):56-9. PubMed ID: 3359354
[TBL] [Abstract][Full Text] [Related]
4. Effects of cod-liver oil on intimal hyperplasia in vein grafts used for arterial bypass.
Landymore RW; MacAulay MA; Cooper JH; Sheridan BL
Can J Surg; 1986 Mar; 29(2):129-31. PubMed ID: 3006901
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic modulation of intimal hyperplasia in canine vein interposition grafts.
Hirko MK; McShannic JR; Schmidt SP; Sharp WV; Evancho MM; Sims RL; Siebert JD
J Vasc Surg; 1993 May; 17(5):877-87. PubMed ID: 8487356
[TBL] [Abstract][Full Text] [Related]
6. Reduction of intimal hyperplasia in canine autologous vein grafts with cod-liver oil and dipyridamole.
Landymore RW; Cameron CA; Sheridan BL; MacAuley MA
Can J Surg; 1986 Sep; 29(5):357-8. PubMed ID: 3019497
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cod-liver oil and aspirin-dipyridamole for the prevention of intimal hyperplasia in autologous vein grafts.
Landymore RW; MacAulay M; Sheridan B; Cameron C
Ann Thorac Surg; 1986 Jan; 41(1):54-7. PubMed ID: 3942432
[TBL] [Abstract][Full Text] [Related]
8. Effects of low-dose marine oils on intimal hyperplasia in autologous vein grafts.
Landymore RW; Manku MS; Tan M; MacAulay MA; Sheridan B
J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 1):788-91. PubMed ID: 2554068
[TBL] [Abstract][Full Text] [Related]
9. Prevention of intimal hyperplasia by single-dose pre-insertion external radiation in canine-vein interposition grafts.
Ulus AT; Tütün U; Zorlu F; Can C; Apaydin N; Karacagil S; Katircioğlu SF; Bayazit M
Eur J Vasc Endovasc Surg; 2000 May; 19(5):456-60. PubMed ID: 10828224
[TBL] [Abstract][Full Text] [Related]
10. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.
el-Sanadiki MN; Cross KS; Murray JJ; Schuman RW; Mikat E; McCann RL; Hagen PO
Ann Surg; 1990 Jul; 212(1):87-96. PubMed ID: 2363608
[TBL] [Abstract][Full Text] [Related]
11. The reversibility of canine vein-graft arterialization.
Fann JI; Sokoloff MH; Sarris GE; Yun KL; Kosek JC; Miller DC
Circulation; 1990 Nov; 82(5 Suppl):IV9-18. PubMed ID: 2225440
[TBL] [Abstract][Full Text] [Related]
12. Hemagglutinating virus of Japan-liposome-mediated gene transfer of endothelial cell nitric oxide synthase inhibits intimal hyperplasia of canine vein grafts under conditions of poor runoff.
Matsumoto T; Komori K; Yonemitsu Y; Morishita R; Sueishi K; Kaneda Y; Sugimachi K
J Vasc Surg; 1998 Jan; 27(1):135-44. PubMed ID: 9474091
[TBL] [Abstract][Full Text] [Related]
13. Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia.
Petrofski JA; Hata JA; Gehrig TR; Hanish SI; Williams ML; Thompson RB; Parsa CJ; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):27-33. PubMed ID: 14752409
[TBL] [Abstract][Full Text] [Related]
14. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
15. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production.
Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K
J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127
[TBL] [Abstract][Full Text] [Related]
16. [Local shRNA modulation of phosphatidylinositol 3-kinase signaling pathway reduces intimal hyperplasia in vein grafts: experiment with rats].
Deng YZ; Liu SJ; Ma L; Sun ZQ; Chen JJ; Su G; Liu C; Wang GH; Ke J
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1713-6. PubMed ID: 17825157
[TBL] [Abstract][Full Text] [Related]
17. A novel biodegradable external mesh stent improved long-term patency of vein grafts by inhibiting intimal-medial hyperplasia in an experimental canine model.
Sato A; Kawamoto S; Watanabe M; Suzuki Y; Takahashi G; Masaki N; Kumagai K; Saijo Y; Tabayashi K; Saiki Y
Gen Thorac Cardiovasc Surg; 2016 Jan; 64(1):1-9. PubMed ID: 26419247
[TBL] [Abstract][Full Text] [Related]
18. Pre- vs postoperative pharmacologic inhibition of platelets: effect on intimal hyperplasia in canine autogenous vein grafts.
Dobrin PB; Golan J; Fareed J; Blakeman B; Littoy FN
J Cardiovasc Surg (Torino); 1992; 33(6):705-9. PubMed ID: 1287008
[TBL] [Abstract][Full Text] [Related]
19. A canine model of intimal hyperplasia (IH) in autogenous vein grafting: a preliminary report.
Schmidt SP; Workman JR; Evancho MM; Sims RL; Meerbaum SO; Donovan DL; Sharp WV
J Invest Surg; 1990; 3(4):357-64. PubMed ID: 2291893
[TBL] [Abstract][Full Text] [Related]
20. All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo.
Leville CD; Dassow MS; Seabrook GR; Jean-Claude JM; Towne JB; Cambria RA
J Surg Res; 2000 May; 90(2):183-90. PubMed ID: 10792961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
